Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues

S. Osman, G. Rowlinson-Busza, S. K. Luthra, E. O. Aboagye, G. D. Brown, F. Brady, R. Myers, S. A. Gamage, W. A. Denny, B. C. Baguley, P. M. Price

    Research output: Contribution to journalArticlepeer-review

    Abstract

    The tricyclic carboxamide N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) is a DNA-intercalating agent capable of inhibiting both topoisomerases I and II and is currently in Phase II clinical trial. Many related analogues have been developed, but despite their potent in vitro cytotoxicities, they exhibit poor extravascular distribution. As part of an ongoing drug development program to obtain related "minimal intercalators" with lower DNA association constants, we have compared the biodistribution and metabolite profiles of the prototype compound, DACA, with three analogues to aid rational drug selection. All of these compounds share a common structural feature, N-dimethyl side chain, which was radiolabeled with the positron-emitting radioisotope, carbon-11. This strategy was selected because it allows promising candidates emerging from preclinical studies in animals to be evaluated rapidly in humans using positron emission tomography (PET). The acridine DACA, the phenazine SN 23490, the pyridoquinoline SN 23719, and the dibenzodioxin SN 23935 were found to be cytotoxic in in vitro assays with an IC50 of 1.4-1.8 μM, 0.4-0.6 μM, 1.3-1.6 μM, and 24-36 μM, respectively, in HT29, U87MG, and A375M cell lines. Ex vivo biodistribution studies with carbon-11 radiolabeled compounds in mice bearing human tumor xenografts showed rapid clearance of 11C-radioactivity (parent drug and metabolites) from blood and the major organs. Rapid hepatobiliary clearance and renal excretion were also observed. There was low [
    Original languageEnglish
    Pages (from-to)2935-2944
    Number of pages9
    JournalCancer Research
    Volume61
    Issue number7
    Publication statusPublished - 1 Apr 2001

    Keywords

    • chemistry: Acridines
    • Animals
    • metabolism: Antineoplastic Agents
    • diagnostic use: Carbon Radioisotopes
    • Comparative Study
    • Female
    • drug therapy: Glioma
    • HT29 Cells
    • Humans
    • Inhibitory Concentration 50
    • metabolism: Intercalating Agents
    • Isotope Labeling
    • drug therapy: Melanoma
    • Mice
    • Mice, Inbred ICR
    • Mice, Nude
    • Research Support, Non-U.S. Gov't
    • Tissue Distribution
    • Tomography, Emission-Computed
    • Tumor Cells, Cultured
    • Xenograft Model Antitumor Assays

    Fingerprint

    Dive into the research topics of 'Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues'. Together they form a unique fingerprint.

    Cite this